Evolution of the Average Target: Almarai Company

Evolution of the Target Price: Almarai Company

Changes in Analyst Recommendations: Almarai Company

81b871fdea6f4c9.DrZeC7jHHvXdVNCn9gZWFmn7pNu6y-Q-ldOyZBVE4kQ.dPkNOfqhW6-FYOPgxTEAUySU9rKJub5hw7XXEC19ugo7gwZK8r1owrMGlQ~668fcbadac37349a4382a66e830b0ae8
28/08 AlphaMena Downgrades Almarai to Reduce Rating, Trims PT MT
21/08 Sadif Investment Analytics Upgrades Almarai to Hold, Raises PT MT
21/07 Al Rajhi Capital Lifts Almarai's PT, Affirms Neutral Rating MT
20/07 UBS Raises Almarai's PT, Affirms Neutral Rating MT
14/07 Citi Trims Almarai's PT, Affirms Buy Rating MT
10/07 AlphaMena Lifts Almarai's PT, Maintains Add Rating MT
07/07 Riyad Capital Affirms Almarai Co at Neutral After Q2 Results MT
02/07 AlphaMena Keeps Almarai at Add Rating, Lifts PT MT
25/06 EFG-Hermes Brokerage Raises Almarai PT, Keeps at Buy MT
04/06 Morgan Stanley Lifts Almarai's PT, Affirms Overweight Rating MT
01/06 BSF Capital Reduces Almarai's PT, Affirms Buy Rating MT
22/05 Sadif Investment Analytics Downgrades Almarai to Sell, Trims PT MT
18/05 EFG-Hermes Brokerage Lowers Almarai PT, Affirms Buy Rating MT
17/04 AlphaMena Lifts Almarai PT, Maintains Add Rating MT
16/04 United Securities Notes Almarai's Q1 Beat Despite Regional Tensions; Buy Rating Provided MT
10/04 FAB Securities Reduce Almarai's PT, Keeps at Buy MT
06/04 Arqaam Capital Reduces Almarai's PT, Affirms Buy Rating MT
03/04 AlphaMena Maintains Almarai at Add Rating, Lifts PT MT
01/04 Morgan Stanley Keeps Almarai at Overweight, Lowers PT MT
02/03 JPMorgan Lowers Almarai PT, Maintains Overweight Rating MT
20/02 AlphaMena Downgrades Almarai to Add, Reduces PT MT
20/02 Sadif Investment Analytics Reduces Almarai's PT, Affirms Hold Rating MT
03/02 Aljazira Capital Upgrades Almarai to Overweight, Reduces PT MT
29/01 EFG-Hermes Brokerage Cuts Almarai PT, Keeps Buy Rating MT
27/01 AlphaMena Reduces Almarai PT, Affirms Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.69%
+12.11%
+11.37%
+24.49%
-3.19%
+16.64%
+12.99%
-2.27%
Average +11.23%
Weighted average by Cap. +11.66%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
48.10SAR
Average target price
57.67SAR
Spread / Average Target
+19.89%
High Price Target
68.00SAR
Spread / Highest target
+41.37%
Low Price Target
50.00SAR
Spread / Lowest Target
+3.95%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. 2280 Stock
  4. Consensus Almarai Company